Overview
Centene Corporation, headquartered in the United States, operates primarily within the healthcare sector, focusing on diversified healthcare services. It specializes in providing government-sponsored healthcare programs, emphasizing managed care for uninsured, underinsured, and low-income individuals. Centene is notable for its extensive portfolio of health solutions through a wide network of local health plans. Key projects typically include Medicaid and Medicare programs, along with other insurance solutions such as private insurance under the Affordable Care Act. By continuously evolving, Centene aims to enhance accessibility to quality healthcare, invest in technology that improves patient outcomes, and expand its market reach to effectively manage healthcare services across a complex consumer base nationally.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Centene Corporation as of June 30, 2025 is 159,560.00 MM.
- The operating income for Centene Corporation as of June 30, 2025 is 3,396.00 MM.
- The net income for Centene Corporation as of June 30, 2025 is 2,054.00 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 159,560.00 | 3,396.00 | 2,054.00 |
2025-03-31 | 153,158.00 | 5,129.00 | 3,453.00 |
2024-12-31 | 147,169.00 | 4,947.00 | 3,305.00 |
2024-09-30 | 146,455.00 | 4,941.00 | 3,067.00 |
2024-06-30 | 144,305.00 | 5,263.00 | 2,823.00 |
2024-03-31 | 143,049.00 | 5,106.00 | 2,735.00 |
2023-12-31 | 141,393.00 | 4,913.00 | 2,702.00 |
2023-09-30 | 139,364.00 | 5,096.00 | 2,444.00 |
2023-06-30 | 138,111.00 | 4,668.00 | 2,713.00 |
2023-03-31 | 136,941.00 | 4,514.00 | 1,483.00 |
2022-12-31 | 135,999.00 | 4,379.00 | 1,202.00 |
2022-09-30 | 132,756.00 | 4,469.00 | 2,014.00 |
2022-06-30 | 129,228.00 | 4,183.00 | 1,860.00 |
2022-03-31 | 124,181.00 | 3,766.00 | 1,497.00 |
2021-12-31 | 118,573.00 | 4,078.00 | 1,347.00 |
2021-09-30 | 114,130.00 | 3,220.00 | 736.00 |
2021-06-30 | 111,284.00 | 3,524.00 | 720.00 |
2021-03-31 | 108,158.00 | 4,751.00 | 2,461.00 |
2020-12-31 | 104,280.00 | 4,214.00 | 1,808.00 |
2020-09-30 | 95,764.00 | 4,263.00 | 2,029.00 |
2020-06-30 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | 6.74 | 6.72 |
2024-12-31 | 6.33 | 6.31 |
2024-09-30 | 5.78 | 5.75 |
2024-06-30 | 5.28 | 5.25 |
2024-03-31 | 5.07 | 5.05 |
2023-12-31 | 4.97 | 4.95 |
2023-09-30 | 4.45 | 4.43 |
2023-06-30 | 4.86 | 4.82 |
2023-03-31 | 2.62 | 2.59 |
2022-12-31 | 2.09 | 2.07 |
2022-09-30 | 3.47 | 3.42 |
2022-06-30 | 3.19 | 3.15 |
2022-03-31 | 2.57 | 2.53 |
2021-12-31 | 2.31 | 2.28 |
2021-09-30 | 1.26 | 1.25 |
2021-06-30 | 1.24 | 1.22 |
2021-03-31 | 4.24 | 4.18 |
2020-12-31 | 3.17 | 3.12 |
2020-09-30 | 3.83 | 3.77 |
2020-06-30 | 3.19 | 3.14 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Centene Corporation as of June 30, 2025 is 1,730.00 MM.
- The cash from investing activities for Centene Corporation as of June 30, 2025 is -2,165.00 MM.
- The cash from financing activities for Centene Corporation as of June 30, 2025 is -2,682.00 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 1,730.00 | -2,165.00 | -2,682.00 |
2025-03-31 | 2,120.00 | -2,433.00 | -2,679.00 |
2024-12-31 | 154.00 | -1,052.00 | -2,406.00 |
2024-09-30 | 958.00 | -2,103.00 | -2,594.00 |
2024-06-30 | 2,957.00 | -829.00 | -1,873.00 |
2024-03-31 | 3,328.00 | -86.00 | -1,452.00 |
2023-12-31 | 8,053.00 | -1,191.00 | -1,658.00 |
2023-09-30 | 6,260.00 | -21.00 | -3,189.00 |
2023-06-30 | 8,571.00 | -453.00 | -4,146.00 |
2023-03-31 | 9,379.00 | -773.00 | -3,882.00 |
2022-12-31 | 6,261.00 | -2,921.00 | -4,197.00 |
2022-09-30 | 8,512.00 | -3,999.00 | -2,700.00 |
2022-06-30 | 6,982.00 | -5,024.00 | 424.00 |
2022-03-31 | 5,313.00 | -5,093.00 | 937.00 |
2021-12-31 | 4,205.00 | -3,299.00 | 1,362.00 |
2021-09-30 | 6,511.00 | -6,697.00 | 1,474.00 |
2021-06-30 | 3,757.00 | -5,343.00 | -165.00 |
2021-03-31 | 5,786.00 | -4,290.00 | -652.00 |
2020-12-31 | 5,503.00 | -6,955.00 | 260.00 |
2020-09-30 | 1,871.00 | -2,844.00 | 7,087.00 |
2020-06-30 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 |
Management Effectiveness
- The roe for Centene Corporation as of June 30, 2025 is 0.00.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | 0.00 | ||||
2025-03-31 | 0.00 | ||||
2024-12-31 | 0.00 | ||||
2024-09-30 | 0.00 | ||||
2024-06-30 | 0.00 | ||||
2024-03-31 | 0.00 | ||||
2023-12-31 | 0.00 | ||||
2023-09-30 | 0.00 | ||||
2023-06-30 | 0.00 | ||||
2023-03-31 | 0.00 | ||||
2022-12-31 | 0.00 | ||||
2022-09-30 | 0.00 | ||||
2022-06-30 | 0.00 | ||||
2022-03-31 | 0.00 | ||||
2021-12-31 | 0.00 | ||||
2021-09-30 | 0.00 | ||||
2021-06-30 | 0.00 | ||||
2021-03-31 | 0.00 | ||||
2020-12-31 | 0.04 | 0.14 | 0.04 | -0.03 | 0.12 |
2020-09-30 | 0.06 | 0.16 | 0.05 | 0.14 | 0.04 |
2020-06-30 | 0.05 | 0.13 | 0.04 | 0.14 | 0.06 |
Gross Margins
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | 0.17 | 0.02 | 0.04 |
2020-09-30 | 0.18 | 0.02 | 0.04 |
2020-06-30 | 0.18 | 0.02 | 0.04 |
Identifiers and Descriptors
Central Index Key (CIK) | 1071739 |
Industry Groups
SIC 6324 - Hospital and Medical Service Plans |